Condition

Post-Polycythemia Vera (2)

Primary Myelofibrosis (2)

Post-Essential Thrombocythemia Myelofibrosis (1)

Post-Essential Thrombocytopenia (1)

Overall Status

Completed (1)

Terminated (1)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Novartis Pharmaceuticals (1)

Sierra Oncology, Inc. (1)

Collaborator

Intervention

momelotinib (1)

panobinostat (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

Post-Polycythemia Vera

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Primary Myelofibrosis, Post-Polycythemia Vera, Post-Essential Thrombocytopenia Trial in United States (Panobinostat)

Terminated

Primary Myelofibrosis
+2 more

Panobinostat

Scottsdale, Arizona
+8 more

Jul 9, 2021

Primary Myelofibrosis, Post-Polycythemia Vera, Post-Essential Thrombocythemia Myelofibrosis Trial in Canada, United States

Completed

Primary Myelofibrosis
+2 more

Momelotinib

Scottsdale, Arizona
+5 more

Jan 31, 2019